Armata Pharmaceuticals Inc (ARMP) — Cash Flow-to-Debt Ratio
Armata Pharmaceuticals Inc (ARMP) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of $-6.67 Million could theoretically repay 0% of its total liabilities ($295.48 Million) in one year. See ARMP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Armata Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Armata Pharmaceuticals Inc across 31 annual periods. Also explore Armata Pharmaceuticals Inc (ARMP) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Armata Pharmaceuticals Inc (1993–2025)
Year-by-year debt coverage analysis for Armata Pharmaceuticals Inc. For market capitalisation and broader financial context, see Armata Pharmaceuticals Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-25.76 Million | $295.48 Million | ▲ +68.8% |
| 2024 | -0.28x | $-37.55 Million | $134.46 Million | ▲ +23.2% |
| 2023 | -0.36x | $-47.42 Million | $130.43 Million | ▲ +19.6% |
| 2022 | -0.45x | $-32.48 Million | $71.80 Million | ▲ +14.9% |
| 2021 | -0.53x | $-23.57 Million | $44.37 Million | ▲ +39.9% |
| 2020 | -0.88x | $-18.27 Million | $20.66 Million | ▲ +38.4% |
| 2019 | -1.44x | $-15.58 Million | $10.86 Million | ▲ +47.8% |
| 2018 | -2.75x | $-9.38 Million | $3.41 Million | ▼ -1.9% |
| 2017 | -2.70x | $-9.19 Million | $3.41 Million | ▼ -115.9% |
| 2016 | -1.25x | $-10.59 Million | $8.47 Million | ▼ -140.0% |
| 2015 | -0.52x | $-9.78 Million | $18.78 Million | ▼ -4.3% |
| 2014 | -0.50x | $-12.57 Million | $25.18 Million | ▼ -249.7% |
| 2013 | -0.14x | $-7.45 Million | $52.17 Million | ▲ +69.6% |
| 2012 | -0.47x | $-4.28 Million | $9.13 Million | ▲ +56.5% |
| 2011 | -1.08x | $-4.67 Million | $4.33 Million | ▼ -14.3% |
| 2008 | -0.94x | $-10.30 Million | $10.92 Million | ▲ +16.8% |
| 2007 | -1.13x | $-13.88 Million | $12.23 Million | ▼ -18.0% |
| 2006 | -0.96x | $-11.64 Million | $12.10 Million | ▼ -6.9% |
| 2005 | -0.90x | $-16.39 Million | $18.23 Million | ▼ -17.0% |
| 2004 | -0.77x | $-15.52 Million | $20.20 Million | ▼ -60.4% |
| 2003 | -0.48x | $-11.23 Million | $23.44 Million | ▼ -9.8% |
| 2002 | -0.44x | $-20.10 Million | $46.07 Million | ▲ +37.7% |
| 2001 | -0.70x | $-23.54 Million | $33.64 Million | ▼ -2736.7% |
| 2000 | -0.02x | $-605.54K | $24.54 Million | ▲ +98.4% |
| 1999 | -1.58x | $-10.60 Million | $6.70 Million | ▼ -14.6% |
| 1998 | -1.38x | $-5.80 Million | $4.20 Million | ▲ +53.6% |
| 1997 | -2.98x | $-12.50 Million | $4.20 Million | ▼ -60.3% |
| 1996 | -1.86x | $-10.40 Million | $5.60 Million | ▲ +8.2% |
| 1995 | -2.02x | $-8.50 Million | $4.20 Million | ▼ -6.8% |
| 1994 | -1.89x | $-7.20 Million | $3.80 Million | ▲ +18.2% |
| 1993 | -2.32x | $-4.40 Million | $1.90 Million | — |